VILDIABATE M 1000: Uses, Side effect, Interactions, Dosage ,ETC......

May 04, 2024

VILDIABATE M 1000

Metformin (1000mg)SR + Vildagliptin (50mg)

VILDIABATE M 1000 is a combination medication formulated with Metformin SR (1000mg) and Vildagliptin (50mg), designed specifically for the treatment of type 2 diabetes. This dual therapy is aimed at enhancing glycemic control through complementary mechanisms of action.

Mechanism of Action

  • Metformin SR (1000mg): Metformin SR, a sustained-release formulation, works by improving insulin sensitivity, reducing hepatic glucose production, and decreasing intestinal absorption of glucose. Its slow release helps in maintaining stable blood glucose levels with fewer gastrointestinal side effects.
  • Vildagliptin (50mg): As a dipeptidyl peptidase-4 (DPP-4) inhibitor, Vildagliptin enhances the function of incretin hormones, which increases insulin release in response to meals and decreases glucagon secretion when glucose levels are high.

Benefits of VILDIABATE M 1000

  • Enhanced Glycemic Control: By combining Metformin and Vildagliptin, VILDIABATE M 1000 targets multiple pathways in glucose metabolism, providing effective control over both fasting and postprandial blood glucose levels.
  • Reduced Risk of Hypoglycemia: The combination ensures a lower risk of hypoglycemia compared to other therapies that stimulate insulin secretion regardless of blood sugar levels.
  • Improved Compliance: The formulation in one pill simplifies the treatment regimen, enhancing patient adherence.

Recommended Dosage Patients typically take one tablet of VILDIABATE M 1000 daily with meals. However, dosage adjustments may be required based on individual response and tolerance, under the supervision of a healthcare provider.

Potential Side Effects Common side effects include gastrointestinal issues from Metformin and potential headaches or nasopharyngitis from Vildagliptin. These are generally mild and manageable with supportive care and adjustment of dosing schedules.

Conclusion VILDIABATE M 1000 represents a significant advancement in the pharmacological management of type 2 diabetes, offering a convenient and effective way to control blood sugar levels with minimal side effects.Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

 For further information: 

  EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

 CALL/WHATSAPP: 7877551268, 7849827488

 BUY NOW

 

SHARE WITH